Literature DB >> 9740886

Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation.

L S Franck1, J Vilardi, D Durand, R Powers.   

Abstract

BACKGROUND: Complications of opioid analgesia include tolerance and withdrawal.
OBJECTIVES: To determine the effects of morphine and fentanyl on the prevalence of withdrawal after extracorporeal membrane oxygenation.
METHODS: Two groups of neonates were compared during and after extracorporeal membrane oxygenation: a prospective group receiving a continuous infusion of morphine for analgesia and sedation and a retrospective group who had received a continuous infusion of fentanyl.
RESULTS: Neonates receiving morphine required significantly less supplemental analgesia (P < .001) than did neonates who had received fentanyl and had a significantly lower prevalence of withdrawal after the therapy (P = .01). Neonates receiving morphine were discharged from the hospital a mean of 9.6 days sooner (P = .01) than neonates who had received fentanyl.
CONCLUSIONS: Morphine may offer marked advantages over fentanyl for providing continuous analgesia and sedation in neonates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740886

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  38 in total

1.  Can we use methadone for analgesia in neonates?

Authors:  S K Chana; K J Anand
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

Review 2.  Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.

Authors:  Matteo Di Nardo; Enno Diederick Wildschut
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 3.  Pharmacological therapy for analgesia and sedation in the newborn.

Authors:  K J S Anand; R W Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

4.  Sedation Management in Children Supported on Extracorporeal Membrane Oxygenation for Acute Respiratory Failure.

Authors:  James B Schneider; Todd Sweberg; Lisa A Asaro; Aileen Kirby; David Wypij; Ravi R Thiagarajan; Martha A Q Curley
Journal:  Crit Care Med       Date:  2017-10       Impact factor: 7.598

5.  Reduced narcotic and sedative utilization in a NICU after implementation of pain management guidelines.

Authors:  D Rana; B Bellflower; J Sahni; A J Kaplan; N T Owens; E L Arrindell; A J Talati; R Dhanireddy
Journal:  J Perinatol       Date:  2017-06-15       Impact factor: 2.521

Review 6.  Designing drug regimens for special intensive care unit populations.

Authors:  Brian L Erstad
Journal:  World J Crit Care Med       Date:  2015-05-04

Review 7.  Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model.

Authors:  Kaitlin M Best; Joseph I Boullata; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2015-02       Impact factor: 3.624

8.  The Impact of a Clonidine Transition Protocol on Dexmedetomidine Withdrawal in Critically Ill Pediatric Patients.

Authors:  JiTong Liu; Jessica Miller; Michael Ferguson; Sandra Bagwell; Jonathan Bourque
Journal:  J Pediatr Pharmacol Ther       Date:  2020

Review 9.  Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates.

Authors:  Marcia L Buck
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Perioperative care following complex laryngotracheal reconstruction in infants and children.

Authors:  Punkaj Gupta; Joseph D Tobias; Sunali Goyal; Jacob E Kuperstock; Sana F Hashmi; Jennifer Shin; Christopher J Hartnick; Natan Noviski
Journal:  Saudi J Anaesth       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.